• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correspondence on ': hydroxychloroquine, COVID-19 and the role of the rheumatologist' by Graef .

作者信息

Lo Chien Hsien, Wang Yu-Hsun, Tsai Chin Feng, Chan Kuei Chuan, Li Li Ching, Lo Tse Hsien, Su Chun Hung, Wei James Cheng-Chung

机构信息

Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

Division of Cardiology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.

出版信息

Ann Rheum Dis. 2022 Aug 11;81(9):e163. doi: 10.1136/annrheumdis-2020-218589.

DOI:10.1136/annrheumdis-2020-218589
PMID:32769154
Abstract
摘要

相似文献

1
Correspondence on ': hydroxychloroquine, COVID-19 and the role of the rheumatologist' by Graef .关于格雷夫的《羟氯喹、2019冠状病毒病及风湿病学家的作用》的通信
Ann Rheum Dis. 2022 Aug 11;81(9):e163. doi: 10.1136/annrheumdis-2020-218589.
2
Response to: 'Correspondence on ': hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef ' by Lo .对洛（Lo）就格雷夫（Graef）的《关于羟氯喹、2019冠状病毒病及风湿病学家的作用的通信》的回复。
Ann Rheum Dis. 2022 Aug 11;81(9):e164. doi: 10.1136/annrheumdis-2020-218680.
3
: hydroxychloroquine, COVID-19 and the role of the rheumatologist.羟氯喹、2019冠状病毒病与风湿病学家的作用
Ann Rheum Dis. 2020 Jun;79(6):734-736. doi: 10.1136/annrheumdis-2020-217480. Epub 2020 Apr 15.
4
Commentary on Levine et al: Festina Lente (Rush Slowly).
J Sex Marital Ther. 2022;48(8):775-778. doi: 10.1080/0092623X.2022.2055686. Epub 2022 Mar 23.
5
Referrals to hospital-based rheumatology and orthopaedic services: seeking direction.转诊至医院的风湿病科和骨科服务：寻求指导。
Rheumatology (Oxford). 2005 Apr;44(4):469-71. doi: 10.1093/rheumatology/keh504. Epub 2005 Feb 16.
6
Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie .对于抗疟药物在风湿性疾病患者的新型冠状病毒肺炎治疗中明确作用的界定仍为时过早。回应：谢的“羟氯喹降低风湿性疾病患者感染新型冠状病毒肺炎的风险：神话还是现实？”
Ann Rheum Dis. 2021 Jan;80(1):e7. doi: 10.1136/annrheumdis-2020-217633. Epub 2020 Jun 22.
7
Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev .2019冠状病毒病（COVID-19）患者同时存在的合并症和风湿性疾病。回应：莫伊谢耶夫所著的《COVID-19重症监护病房患者的风湿性疾病》
Ann Rheum Dis. 2021 Feb;80(2):e17. doi: 10.1136/annrheumdis-2020-217800. Epub 2020 May 20.
8
Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis.羟氯喹与甲氨蝶呤治疗类风湿关节炎患者的心血管风险比较。
J Am Coll Cardiol. 2022 Jul 5;80(1):36-46. doi: 10.1016/j.jacc.2022.04.039.
9
Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.羟氯喹和氯喹：评估视网膜毒性风险。
J Am Optom Assoc. 1993 Nov;64(11):787-97.
10
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study.单独使用羟氯喹及联合阿奇霉素治疗类风湿关节炎的风险：一项多国回顾性研究。
Lancet Rheumatol. 2020 Nov;2(11):e698-e711. doi: 10.1016/S2665-9913(20)30276-9. Epub 2020 Aug 21.

引用本文的文献

1
Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study.羟氯喹与系统性红斑狼疮患者心律失常的相关性：一项基于人群的病例对照研究。
PLoS One. 2021 May 20;16(5):e0251918. doi: 10.1371/journal.pone.0251918. eCollection 2021.
2
Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.羟氯喹不会增加常见风湿性疾病中心律失常的风险：一项全国范围内基于人群的队列研究。
Front Immunol. 2021 Apr 2;12:631869. doi: 10.3389/fimmu.2021.631869. eCollection 2021.
3
Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain?
羟氯喹治疗 COVID-19 及其潜在心血管毒性：英雄还是恶棍？
Best Pract Res Clin Rheumatol. 2021 Mar;35(1):101658. doi: 10.1016/j.berh.2020.101658. Epub 2021 Jan 1.
4
Response to: 'Correspondence on ': hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef ' by Lo .对洛（Lo）就格雷夫（Graef）的《关于羟氯喹、2019冠状病毒病及风湿病学家的作用的通信》的回复。
Ann Rheum Dis. 2022 Aug 11;81(9):e164. doi: 10.1136/annrheumdis-2020-218680.